Skip to main content
Back
Talent

OICR’s Dr. John Bartlett named one of the top-cited authors in the Journal of Clinical Oncology

Article1 min read
Dr. John Bartlett

The Journal of Clinical Oncology (JCO), one of the most prestigious journals in cancer research, recently added Dr. John Bartlett to its list of most-cited authors following an analysis by the analytics firm Clarivate. A clinical practice guideline update by Bartlett and his coauthors was the third most-cited article JCO published in 2018. The guideline, on HER2 testing in breast cancer, has been cited an outstanding 276 times. Bartlett is Director of OICR’s Diagnostic Development Program, which is working to develop new tools to guide precision medicine for cancer.

Related researchers and programs

Newsletter signup

Cancer solved together — in your inbox

The latest findings, funding, and partnerships from Ontario’s cancer research institute. Briefings and deeper dives.

Subscribe
More stories

Discover more stories

TalentPrevention

Q&A with Dr. Isaac Harris

New OICR Investigator discusses coming home to Ontario, the link between antioxidants and cancer, and how he wants his research to help improve your diet. Dr. Isaac Harris was recently recruited to McMaster University and…
Article
Ella Zwep OHCRN intern
Talent

Ella Zwep aiming to improve Indigenous representation in cancer research

The Laurier University undergraduate’s summer internship is focused on Indigenous recruitment to the Ontario Hereditary Cancer Research Network (OHCRN). Despite their history of prostate cancer, Ella Zwep knows her family is lucky. Living in southwestern…
Article